Broggi, G.; Barbagallo, D.; Lacarrubba, F.; Verzì, A.E.; Micali, G.; Purrello, M.; Caltabiano, R.
The Immunohistochemical Expression of the Serine and Arginine-Rich Splicing Factor 1 (SRSF1) Is a Predictive Factor of the Recurrence of Basal Cell Carcinoma: A Preliminary Study on a Series of 52 Cases. Medicina 2022, 58, 139.
https://doi.org/10.3390/medicina58010139
AMA Style
Broggi G, Barbagallo D, Lacarrubba F, Verzì AE, Micali G, Purrello M, Caltabiano R.
The Immunohistochemical Expression of the Serine and Arginine-Rich Splicing Factor 1 (SRSF1) Is a Predictive Factor of the Recurrence of Basal Cell Carcinoma: A Preliminary Study on a Series of 52 Cases. Medicina. 2022; 58(1):139.
https://doi.org/10.3390/medicina58010139
Chicago/Turabian Style
Broggi, Giuseppe, Davide Barbagallo, Francesco Lacarrubba, Anna Elisa Verzì, Giuseppe Micali, Michele Purrello, and Rosario Caltabiano.
2022. "The Immunohistochemical Expression of the Serine and Arginine-Rich Splicing Factor 1 (SRSF1) Is a Predictive Factor of the Recurrence of Basal Cell Carcinoma: A Preliminary Study on a Series of 52 Cases" Medicina 58, no. 1: 139.
https://doi.org/10.3390/medicina58010139
APA Style
Broggi, G., Barbagallo, D., Lacarrubba, F., Verzì, A. E., Micali, G., Purrello, M., & Caltabiano, R.
(2022). The Immunohistochemical Expression of the Serine and Arginine-Rich Splicing Factor 1 (SRSF1) Is a Predictive Factor of the Recurrence of Basal Cell Carcinoma: A Preliminary Study on a Series of 52 Cases. Medicina, 58(1), 139.
https://doi.org/10.3390/medicina58010139
